Systemic injection of antigen is one of the approaches that reproducib
ly induces effective antigen-specific hyporesponsiveness. Here, Roland
Liblau and colleagues discuss the cellular and molecular bases of suc
h tolerance, review the current use of this therapeutic strategy in ex
perimental organ-specific autoimmune diseases and analyse what steps a
re necessary to make this approach suitable for clinical use.